Lv1
70 积分 2024-09-05 加入
A multicenter, randomized, controlled, open-label, phase II trial of autologous tumor-infiltrating lymphocytes (GC101 TIL) in patients with advanced melanoma
5天前
已关闭
Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy
11天前
已完结
IDF diabetes atlas 11th edition 2025: global prevalence and projections for 2050
14天前
已完结
Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: a prospective, open-label and single arm pilot study
24天前
已完结
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial
30天前
已完结
Evaluation of the efficacy and safety of anlotinib in postoperative non-pCR non-small cell lung cancer
1个月前
已关闭
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
1个月前
已完结
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
1个月前
已完结
Idiopathic pulmonary fibrosis: state of the art for 2023
1个月前
已完结
皖公网安备34019202002308
